USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective

dc.contributor	Казанский федеральный университет
dc.contributor.author	Korenev Georgiy
dc.contributor.author	Yakukhnov Sergey
dc.contributor.author	Druk Anastasiya
dc.contributor.author	Golovina Anastasiya
dc.contributor.author	Chasov Vitaly Vasilevich
dc.contributor.author	Mirgayazova Regina Mansurovna
dc.contributor.author	Ivanov Roman
dc.contributor.author	Bulatov Emil Rafaelevich
dc.date.accessioned	2022-12-06T08:14:59Z
dc.date.available	2022-12-06T08:14:59Z
dc.date.issued	2022
dc.identifier.citation	Korenev G. USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective / G. Korenev, S. Yakukhnov, A. Druk, A. Golovina, V. Chasov, R. Mirgayazova, R. Ivanov, E. Bulatov // Cancers. - 2022. - Is.14(22). - P. 5539.
dc.identifier.uri	https://dspace.kpfu.ru/xmlui/handle/net/173376
dc.description.abstract
dc.language.iso	en
dc.relation.ispartofseries	Cancers
dc.rights	открытый доступ
dc.subject	cancer
dc.subject	immunotherapy
dc.subject	small-molecule inhibitors
dc.subject	ubiquitin-specific protease 7
dc.title	USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective
dc.type	Article
dc.contributor.org	Институт фундаментальной медицины и биологии
dc.description.pages	5539-5554
dc.relation.ispartofseries-issue	22
dc.relation.ispartofseries-volume	14
dc.pub-id	273786
dc.identifier.doi	10.3390/cancers14225539